Department of Medical Genetics, Naval Medical University, Shanghai, 200433, China.
Department of Anatomy, Institute of Biomedical Engineering, Naval Medical University, Shanghai, 200433, China.
Stem Cell Res Ther. 2024 Jul 29;15(1):224. doi: 10.1186/s13287-024-03846-6.
Ferroptosis is associated with the pathological progression of hemorrhagic injury and ischemia-reperfusion injury. According to our previous study, exosomes formed through bone marrow mesenchymal stem cells modified with miR-340-3p (MB-exos) can restore damaged endometrium. However, the involvement of ferroptosis in endometrial injury and the effect of MB-exos on ferroptosis remain elusive.
The endometrial injury rat model was developed. Exosomes were obtained from the supernatants of bone marrow mesenchymal stromal cells (BMSCs) and miR-340/BMSCs through differential centrifugation. We conducted RNA-seq analysis on endometrial tissues obtained from the PBS and MB-exos groups. Ferroptosis was induced in endometrial stromal cells (ESCs) by treating them with erastin or RSL3, followed by treatment with B-exos or MB-exos. We assessed the endometrial total mA modification level after injury and subsequent treatment with B-exos or MB-exos by methylation quantification assay. We performed meRIP-qPCR to analyze mA modification-regulated endogenous mRNAs.
We reveal that MB-exos facilitate the injured endometrium to recover by suppressing ferroptosis in endometrial stromal cells. The injured endometrium showed significantly upregulated N-methyladenosine (mA) modification levels; these levels were attenuated by MB-exos through downregulation of the methylase METTL3. Intriguingly, METTL3 downregulation appears to repress ferroptosis by stabilizing HMOX1 mRNA, thereby potentially elucidating the mechanism through which MB-exos inhibit ferroptosis in ESCs. We identified YTHDF2 as a critical mA reader protein that contributes to HMOX1 mRNA degradation. YTHDF2 facilitates HMOX1 mRNA degradation by identifying the mA binding site in the 3'-untranslated regions of HMOX1. In a rat model, treatment with MB-exos ameliorated endometrial injury-induced fibrosis by inhibiting ferroptosis in ESCs. Moreover, METTL3 short hairpin RNA-mediated inhibition of mA modification enhanced the inhibitory effect of MB-exos on ferroptosis in endometrial injury.
Thus, these observations provide new insights regarding the molecular mechanisms responsible for endometrial recovery promotion by MB-exos and highlight mA modification-dependent ferroptosis inhibition as a prospective therapeutic target to attenuate endometrial injury.
铁死亡与出血性损伤和缺血再灌注损伤的病理进展有关。根据我们之前的研究,通过 miR-340-3p(MB-exos)修饰的骨髓间充质干细胞形成的外泌体可以修复受损的子宫内膜。然而,铁死亡在子宫内膜损伤中的作用以及 MB-exos 对铁死亡的影响仍不清楚。
建立子宫内膜损伤大鼠模型。通过差速离心从骨髓间充质基质细胞(BMSCs)和 miR-340/BMSCs 的上清液中获得外泌体。我们对 PBS 和 MB-exos 组获得的子宫内膜组织进行 RNA-seq 分析。用 erastin 或 RSL3 诱导子宫内膜基质细胞(ESCs)发生铁死亡,然后用 B-exos 或 MB-exos 处理。通过甲基化定量分析评估损伤后和随后用 B-exos 或 MB-exos 处理后的子宫内膜总 mA 修饰水平。我们进行 meRIP-qPCR 分析 mA 修饰调节的内源性 mRNAs。
我们揭示 MB-exos 通过抑制子宫内膜基质细胞中的铁死亡促进受损子宫内膜的恢复。损伤的子宫内膜表现出明显上调的 N-甲基腺苷(mA)修饰水平;这些水平通过下调甲基转移酶 METTL3 被 MB-exos 减弱。有趣的是,METTL3 的下调似乎通过稳定 HMOX1 mRNA 来抑制铁死亡,从而可能阐明 MB-exos 抑制 ESCs 中铁死亡的机制。我们确定 YTHDF2 作为一种关键的 mA 阅读蛋白,有助于 HMOX1 mRNA 的降解。YTHDF2 通过识别 HMOX1 3'-UTR 中的 mA 结合位点促进 HMOX1 mRNA 的降解。在大鼠模型中,MB-exos 治疗通过抑制 ESCs 中的铁死亡改善了子宫内膜损伤引起的纤维化。此外,METTL3 短发夹 RNA 介导的 mA 修饰抑制增强了 MB-exos 对子宫内膜损伤中铁死亡的抑制作用。
因此,这些观察结果为 MB-exos 促进子宫内膜恢复的分子机制提供了新的见解,并强调 mA 修饰依赖性铁死亡抑制作为减轻子宫内膜损伤的有前途的治疗靶点。